UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022499
Receipt number R000025924
Scientific Title The study for the utility of Nasal High flow system during dental sedation in obesity patients with intellectual disability
Date of disclosure of the study information 2016/08/01
Last modified on 2021/08/10 19:02:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study for the utility of Nasal High flow system during dental sedation in obesity patients with intellectual disability

Acronym

The utility of Nasal High flow system during dental sedation

Scientific Title

The study for the utility of Nasal High flow system during dental sedation in obesity patients with intellectual disability

Scientific Title:Acronym

The utility of Nasal High flow system during dental sedation

Region

Japan


Condition

Condition

Dental diseases

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Intravenous sedation is very useful for dental treatment of patients with intellectual disability. However, we are forced to manage them with deep sedation because their cooperation cannot be obtained. In deep sedation, airway management aimed at maintaining the patient's oxygen levels is important for patient safety. In some patients with intellectual disability, obesity is accompanied because self-dietary control is sometime difficult. These obese patients are more likely to suffer airway blockages and reductions in arterial oxygen saturation (SpO2) than non-obese patients. Therefore, airway obstruction and hypoxia are major incidents that anesthetists often encounter in obese patients.
Nasal high-flow systems (NHFS) are a new type of device that can supply warmed and humidified oxygen at a high flow rate. In a recent study, the use of a NHFS resulted in the better outcome for oxygen therapy in intensive care. Therefore, we hypothesized that the use of NHFS during dental sedation might significantly prevent hypoxia in obese patients. In this crossover study, we will investigate whether NHFS use can improve oxygenation in obese patients during dental sedation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. Minimum arterial oxygen saturation (SAT) during sedation.

Key secondary outcomes

1. The frequency and duration of SAT<=94% during sedation.
2. The frequency and duration of SAT<=90% during sedation.
3. Arterial oxygen pressure and arterial carbon dioxide pressure
4. Assisted ventilation with a bag valve mask


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

The use of Optiflow

Interventions/Control_2

Oxygen administration by normal nasal cannula

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Being aged >= 16 years
2. Exhibiting an ASA physical state of 1 or 2
3. Body Mass Index (BMI) >= 25
4. Suffering from a severe intellectual disability and not cooperating fully with dental treatment

Key exclusion criteria

1. Exhibiting an ASA physical state of >3
2. Being contraindicated for the use of midazolam or propofol.

Target sample size

16


Research contact person

Name of lead principal investigator

1st name Hitoshi
Middle name
Last name Higuchi

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Division name

Department of Dental Anesthesiology and Special Care Dentistry

Zip code

7008525

Address

2-5-1 Shikata-cho Kita-ku, Okayama, Japan

TEL

086-235-6721

Email

higuti@md.okayama-u.ac.jp


Public contact

Name of contact person

1st name Hitoshi
Middle name
Last name Hitoshi

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Division name

Department of Dental Anesthesiology and Special Care Dentistry

Zip code

7008525

Address

2-5-1 Shikata-cho Kita-ku, Okayama, Japan

TEL

086-235-6721

Homepage URL


Email

higuti@md.okayama-u.ac.jp


Sponsor or person

Institute

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Dental Anesthesiology and Special Care Dentistry

Institute

Department

Personal name



Funding Source

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Dental Anesthesiology and Special Care Dentistry

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee

Address

2-5-1 Shikatacho Kita-ku, Okayama, Japan

Tel

086-235-6938

Email

mae6605@adm.okayama-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岡山大学病院(岡山県)


Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 01 Day


Related information

URL releasing protocol

https://doi.org/10.1016/j.joms.2021.04.004

Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.1016/j.joms.2021.04.004

Number of participants that the trial has enrolled

18

Results

The mean minimum arterial oxygen saturation (SpO2) value was significantly higher in the NHFS arm than in the control arm (95.8 (2.1) % vs. 93.6 (4.1) %). Hypoxemic episodes (SpO2: 94% or less) occurred 3 cases (16.7%) in the NHFS arm and 11 case (61.1%) in the control arm (P=0.0076).

Results date posted

2021 Year 08 Month 10 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2021 Year 04 Month 07 Day

Baseline Characteristics

Obese patients (body mass index: 25 or higher) with intellectual disabilities who underwent dental sedation

Participant flow

The subjects were randomly assigned to the control oxygen administration (5 L/min via a nasal cannula) or NHFS (40% O2, 40 L/min, 37 degrees Celsius) arm in alternate shifts as a crossover trial.

Adverse events

None

Outcome measures

Minimum SpO2 value
Incidence rates of hypoxemia(SpO2: 94% or less)
Incidence rates of severe hypoxemia(SpO2: 90% or less)
Partial pressure of arterial O2 (PaO2)
Partial pressure of arterial CO2 (PaCO2)

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 04 Month 22 Day

Date of IRB

2016 Year 07 Month 19 Day

Anticipated trial start date

2017 Year 01 Month 01 Day

Last follow-up date

2018 Year 09 Month 20 Day

Date of closure to data entry


Date trial data considered complete

2021 Year 04 Month 07 Day

Date analysis concluded

2021 Year 04 Month 07 Day


Other

Other related information



Management information

Registered date

2016 Year 05 Month 27 Day

Last modified on

2021 Year 08 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025924


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name